Advertisement Nerites names new CFO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Nerites names new CFO

Nerites, a developer of new synthetic bio-adhesives, has appointed David Sneider as its new CFO.

Most recently, Mr Sneider served as CFO of NimbleGen Systems. Prior to NimbleGen, Mr Sneider was CFO of Third Wave Technologies.

Mr Sneider holds a BBA and JD from Loyola University of Chicago. Mr Sneider’s CPA was awarded by the University of Illinois.

Thomas Mozer, CEO of Nerites, said: “This is a transitional moment for us, as we approach clinical trials for our first set of products. With both corporate partnerships and private financing, our financial picture is becoming more complex. David will provide an experienced hand to guide strategic growth and a commitment to responsible capital management in these difficult economic times. His track record should be very comforting to investors.”